Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The KIDCOV Study: ASSESSMENT of SARS-CoV-2 Without HOSPITALIZATION as a RISK FACTOR for ACUTE KIDNEY INJURY

NCT04705766 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT04705766
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04705766 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The KIDCOV Study: ASSESSMENT of SARS-CoV-2 Without HOSPITALIZATION as a RISK FACTOR for ACUTE KIDNEY INJURY
Lead sponsor
University of California, San Francisco
Phase
Observational
Overall status
Enrolling by invitation
Start date
March 1, 2021
Completion date
March 31, 2027
Enrollment
2,000 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

acute kidney injury, corona virus infection, covid19, kidney injury, sars-cov infection